Patent · US Active

Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions

US8691853B2 · kind B2 · utility

0Cited by
8References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 5, 2011
Grant dateApr 8, 2014
Priority date—
Expiry dateJan 28, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D271/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Dopamine reuptake inhibitors, and their analogs, are disclosed for treating and delaying the progression of autoimmune diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.